產(chǎn)品詳情

  • 產(chǎn)品名稱：Caspase-13InhibitorLEED-FMK

  • 產(chǎn)品型號：
  • 產(chǎn)品廠商：Biovision
  • 產(chǎn)品文檔：
你添加了1件商品 查看購物車
簡單介紹：
Caspase-13InhibitorLEED-FMK
詳情介紹：
Purpose A caspase-13 inhibitor
Sequence Z-Leu-Glu(OMe)-Glu(OMe)-Asp(OMe)-FMK
Characteristics PubChem CID: 44135223
A synthetic peptide inhibitor that inhibits caspase-13 and related caspase activity. FMK inhibitors are irreversible and non-toxic, and can be used in both in vivo and in vitro studies. The inhibitor is designed as a methyl ester to facilitate cell permeability. (CAUTION: If the intended use is on purified or recombinant enzymes, esterase should be added to generate free carboxyl groups).
Purity > 95?% by HPLC
Chemical Name Z-LEED-FMK, Z-LEED-fluoromethylketone, Caspase-13 Inhibitor (fluoromethylketone)
Formula C??H??FN?O??
Permeability Cell-permeable
Solubility In DMSO (10 mM)
Molecular Weight 696.7 g/mol
Application Notes We recommend using 1000-5000X dilutions for inhibiting caspase-13 and related caspase activity (e.g., Add 1 μL to 1-5 mL of culture medium). The optimal doses may vary among different cells and culture conditions. The inhibitor is designed as a methyl ester to facilitate cell permeability.
Restrictions For Research Use only
Format Liquid
Concentration 10 mM
Handling Advice Protect from light and moisture
Storage -20 °C
Expiry Date 12 months
Product cited in: Bian, Sun, Silver, Ho, Marchionni, Caggiano, Stone, Amende, Hampton, Morgan, Yan: "Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins." in: American journal of physiology. Heart and circulatory physiology, Vol. 297, Issue 6, pp. H1974-83, 2009 (PubMed).